BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25304893)

  • 41. Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study.
    Dube PN; Bule SS; Mokale SN; Kumbhare MR; Dighe PR; Ushir YV
    Chem Biol Drug Des; 2014 Oct; 84(4):409-19. PubMed ID: 24636540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CC 05, a novel anti-inflammatory compound, exerts its effect by inhibition of cyclooxygenase-2 activity.
    Yin LL; Zhang WY; Li MH; Shen JK; Zhu XZ
    Eur J Pharmacol; 2005 Sep; 520(1-3):172-8. PubMed ID: 16168408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.
    Hayashi S; Ueno N; Murase A; Nakagawa Y; Takada J
    Eur J Med Chem; 2012 Apr; 50():179-95. PubMed ID: 22373734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, Characterization of Ethyl 5-(substituted)-1H-pyrazole- 3-carboxylate Derivative as Potent Anti-inflammatory Agents.
    Pratik K; Arun K; Neha S; Bhumika Y; Anshuman S; Kumar GS
    Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):32-38. PubMed ID: 29651969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
    Velázquez C; Rao PN; McDonald R; Knaus EE
    Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of 5-trifluoromethyl-4,5-dihydro-1H-pyrazoles on chronic inflammatory pain model in rats.
    Sauzem PD; Sant'Anna Gda S; Machado P; Duarte MM; Ferreira J; Mello CF; Beck P; Bonacorso HG; Zanatta N; Martins MA; Rubin MA
    Eur J Pharmacol; 2009 Aug; 616(1-3):91-100. PubMed ID: 19540223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and antiinflammatory activity of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide.
    Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Pillai KK; Singh S; Bagchi V
    Bioorg Med Chem Lett; 2009 Jan; 19(1):255-8. PubMed ID: 19010670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
    Ranatunge RR; Augustyniak M; Bandarage UK; Earl RA; Ellis JL; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schroeder JD; Shumway MJ; Tam SW; Trocha AM; Young DV
    J Med Chem; 2004 Apr; 47(9):2180-93. PubMed ID: 15084117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New pyrazole derivative 5-[1-(4-fluorophenyl)-1H-pyrazol-4-yl]-2H-tetrazole: synthesis and assessment of some biological activities.
    de Oliveira LP; da Silva DP; Florentino IF; Fajemiroye JO; de Oliveira TS; Marcelino RI; Pazini F; Lião LM; Ghedini PC; de Moura SS; Valadares MC; de Carvalho VV; Vaz BG; Menegatti R; Costa EA
    Chem Biol Drug Des; 2017 Jan; 89(1):124-135. PubMed ID: 27526659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, anti-inflammatory activity and ulcerogenic liability of novel nitric oxide donating/chalcone hybrids.
    Abuo-Rahma Gel-D; Abdel-Aziz M; Mourad MA; Farag HH
    Bioorg Med Chem; 2012 Jan; 20(1):195-206. PubMed ID: 22137931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ligand-based design, synthesis and primary in vivo screening of pyrrole derivatives as potential tricyclic anti-inflammatory agents.
    Bijev A; Yaneva D; Bocheva A; Stoev G
    Arzneimittelforschung; 2006; 56(11):753-9. PubMed ID: 17220053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual anti-inflammatory antimicrobial agents.
    Bekhit AA; Fahmy HT; Rostom SA; El-Din A Bekhit A
    Eur J Med Chem; 2010 Dec; 45(12):6027-38. PubMed ID: 20970223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological evaluation of some hydroxypyrazole derivatives as anti-inflammatory-antimicrobial agents.
    Bekhit AA; Abdel-Rahman HM; Guemei AA
    Arch Pharm (Weinheim); 2006 Feb; 339(2):81-7. PubMed ID: 16470641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of new pyrimidine derivatives with evaluation of their anti-inflammatory and analgesic activities.
    Nofal ZM; Fahmy HH; Zarea ES; El-Eraky W
    Acta Pol Pharm; 2011; 68(4):507-17. PubMed ID: 21796933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel pyrazole derivatives as potential promising anti-inflammatory antimicrobial agents.
    Bekhit AA; Ashour HM; Guemei AA
    Arch Pharm (Weinheim); 2005 Apr; 338(4):167-74. PubMed ID: 15864786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel 2-(nitrooxy)ethyl 2-(4-(substituted phenyl)-2-((substituted phenyl)amino)thiazol-5-yl)acetate as Anti-inflammatory, Analgesic and Nitric Oxide Releasing Agents: Synthesis and Molecular Docking Studies.
    Sarkate AP; Lokwani DK; Karnik KS; Shinde DB
    Antiinflamm Antiallergy Agents Med Chem; 2017; 16(3):153-167. PubMed ID: 29141568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and potential biological activity of some novel 3-[(N-substituted indol-3-yl)methyleneamino]-6-amino-4-aryl-pyrano(2,3-c)pyrazole-5-carbonitriles and 3,6-diamino-4-(N-substituted indol-3-yl)pyrano(2,3-c)pyrazole-5-carbonitriles.
    Mandour AH; El-Sawy ER; Ebaid MS; Hassan SM
    Acta Pharm; 2012 Mar; 62(1):15-30. PubMed ID: 22472446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents.
    Alegaon SG; Alagawadi KR; Garg MK; Dushyant K; Vinod D
    Bioorg Chem; 2014 Jun; 54():51-9. PubMed ID: 24793214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PEG mediated synthesis and pharmacological evaluation of some fluoro substituted pyrazoline derivatives as antiinflammatory and analgesic agents.
    Jadhav SY; Shirame SP; Kulkarni SD; Patil SB; Pasale SK; Bhosale RB
    Bioorg Med Chem Lett; 2013 May; 23(9):2575-8. PubMed ID: 23541672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Permeability changes in response to NONOate and NONOate prodrug derived nitric oxide in a blood-brain barrier model formed by primary porcine endothelial cells.
    Winter S; Konter J; Scheler S; Lehmann J; Fahr A
    Nitric Oxide; 2008 May; 18(3):229-39. PubMed ID: 18284923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.